The 2026 update to the International Classification of Diseases (ICD-11) has officially included “menstrual disorder, not elsewhere classified” as a distinct diagnostic category—expanding recognition of conditions like endometriosis and adenomyosis under a unified medical umbrella. This change, announced by the World Health Organization in May 2026, follows years of advocacy by patient groups, who argue that current diagnostic frameworks obscure the severity and systemic impact of these conditions. The reclassification could improve insurance coverage, research funding, and clinical training, but experts warn implementation will vary widely across Europe’s fragmented healthcare systems.
Why the Renaming Matters: From “Painful Periods” to Recognized Disease
For decades, women with chronic pelvic pain or severe menstrual symptoms have faced a diagnostic odyssey. Doctors often dismiss their complaints as “normal” or refer to vague terms like “dysmenorrhea” or “chronic pelvic pain”—categories that fail to capture the debilitating systemic effects of conditions like endometriosis or adenomyosis.
- Endometriosis (N97.0): Tissue growth outside the uterus, linked to infertility and chronic pain.
- Adenomyosis (N80.1): Uterine lining invasion, causing heavy bleeding and organ compression.
- Primary dysmenorrhea (N94.4): Severe cramps without underlying pathology.
- Chronic pelvic pain (N94.6): Persistent discomfort with no clear cause.
The shift reflects a growing consensus that these conditions are not merely “women’s issues” but systemic diseases with neurological, immunological, and reproductive consequences. “This is about moving from stigma to science,” said a spokesperson for the European Society of Human Reproduction and Embryology, citing Merriam-Webster’s definition of “why” as a metaphor for patient frustration: why does it take an average of 7.5 years to diagnose endometriosis in Europe?
Diagnostic Delays: The Human Cost of Ambiguous Labels
| Condition | Average Diagnosis Delay (Years) | Estimated Undiagnosed Cases (Millions) |
|---|---|---|
| Endometriosis | 7.5 | 2.2 |
| Adenomyosis | 5.1 | 1.8 |
| Chronic Pelvic Pain | 3.8 | 3.1 |
These delays stem from two key factors: clinical inertia and insurance barriers. Many gynecologists lack specialized training in these conditions, while health systems often classify them as “non-urgent,” delaying referrals to specialists.
- Creating standardized language for electronic health records (EHRs), reducing misdiagnosis.
- Triggering automatic alerts for severe symptoms in primary care systems.
- Enabling better epidemiological tracking to identify high-risk populations.
Yet implementation faces hurdles. The UK’s National Health Service, for example, has already begun updating its coding systems, while Germany’s Bundesgesundheitsministerium is still reviewing the changes. “This is a classic case of top-down policy meeting bottom-up resistance,” notes a health policy analyst at the London School of Hygiene & Tropical Medicine. “Doctors in rural clinics may not even know the new codes exist for another 18 months.”
The Insurance Loophole: How Diagnostic Codes Affect Treatment
The financial stakes are high. In France, endometriosis patients report being denied surgery or hormone therapy because their conditions were coded under “chronic pain” rather than a specific disease.
- Expanded coverage: Many European insurers reimburse procedures only for ICD-11-recognized conditions.
- Faster approvals: Specialized treatments (e.g., elagolix for endometriosis) require specific diagnostic codes to bypass prior authorization.
- Workplace accommodations: Countries like Sweden already use ICD-11 to justify disability benefits for chronic pelvic pain.
However, the transition isn’t seamless. Italy’s Servizio Sanitario Nazionale has warned that regional health authorities may interpret the new codes differently, creating patchwork coverage. “A woman in Milan might get laparoscopic surgery covered, while one in Palermo faces a six-month wait,” said a gynecologist at the University of Rome’s endometriosis clinic. The Cambridge Dictionary definition of “why” takes on new urgency: why should geography determine access to life-changing care?
Patient Advocacy: The Campaign That Forced Change
The push for reclassification began in 2020, when the Endometriosis Foundation of America and its European counterparts launched a petition demanding ICD-11 recognition.
- Morbidity evidence: Studies show endometriosis increases risks of ovarian cancer, autoimmune disorders, and depression.
- Economic burden: The EU estimates these conditions cost €12.8 billion annually in lost productivity and healthcare.
- Global disparity: While the US adopted similar codes in 2022, many European countries lagged due to slower regulatory cycles.
Advocates credit the 2024 European Parliament resolution on women’s health with accelerating the process. The resolution explicitly called for “specific ICD-11 codes for menstrual-related disorders” and tied funding to member states’ compliance. “This wasn’t just about changing a label—it was about forcing governments to take these conditions seriously,” said a spokesperson for the European Women’s Lobby.
What Comes Next: Gaps and Opportunities
The ICD-11 update is a victory, but the work isn’t over.
- Physician training: Medical schools across Europe must integrate the new codes into curricula. The European Board and College of Obstetrics and Gynaecology (EBCOG) has pledged to update its exam questions by 2027.
- Data collection: The WHO will track adoption rates, but discrepancies between countries could distort global health statistics. For example, Germany’s coding system may classify adenomyosis differently than Spain’s.
- Pharmaceutical access: New treatments (e.g., gene therapies for endometriosis) will require ICD-11 codes to secure reimbursement. The European Medicines Agency is reviewing whether to mandate code-specific labeling.
On the bright side, the reclassification aligns with broader trends. The EU’s 2025 Health in the Digital Decade strategy prioritizes “precision medicine” for women’s health, and the new codes will feed into AI-driven diagnostic tools. “This is a turning point,” said a reproductive health researcher at Karolinska Institutet. “For the first time, we’re treating these conditions as what they are: systemic diseases, not personal failures.”
For women who’ve spent years fighting for answers, the change is long overdue. But the real test will be whether healthcare systems—from Athens to Stockholm—actually use the new codes to improve care. The definitions.net entry for “why” offers a blunt reminder: why did it take so long? And why will some systems still resist?
For readers experiencing symptoms, consult a gynecologist or specialist for evaluation. The new ICD-11 codes may help streamline diagnosis, but individual cases require professional assessment.